A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer
Clinical trial NCT05801783 · UNKNOWN
Trial details
- NCT number
- NCT05801783
- Sponsor
- Shanghai Yunying Medical Technology
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-02
- Primary completion
- 2024-12-02
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.